Source: Interactive cardiovascular and thoracic surgery. Unidade: FM
Subjects: PEPTÍDEO NATRIURÉTICO ATRIAL, MIOCARDIOPATIA HIPERTRÓFICA, BIOMARCADORES, ISQUEMIA MIOCÁRDICA, HEMODINÂMICA, INFLAMAÇÃO, PROCEDIMENTOS CIRÚRGICOS CARDÍACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GANEM, Fernando et al. Preoperative B-type natriuretic peptide, and not the inflammation status, predicts an adverse outcome for patients undergoing heart surgery. Interactive cardiovascular and thoracic surgery, v. 12, n. 12, p. 778-783, 2011Tradução . . Disponível em: https://doi.org/10.1510/icvts.2010.255257. Acesso em: 15 out. 2024.APA
Ganem, F., Serramo Jr., C. V., Blotta, M. H. S. L., Souza, J. A., Nicolau, J. C., Ramires, J. A. F., & Hueb, W. A. (2011). Preoperative B-type natriuretic peptide, and not the inflammation status, predicts an adverse outcome for patients undergoing heart surgery. Interactive cardiovascular and thoracic surgery, 12( 12), 778-783. doi:10.1510/icvts.2010.255257NLM
Ganem F, Serramo Jr. CV, Blotta MHSL, Souza JA, Nicolau JC, Ramires JAF, Hueb WA. Preoperative B-type natriuretic peptide, and not the inflammation status, predicts an adverse outcome for patients undergoing heart surgery [Internet]. Interactive cardiovascular and thoracic surgery. 2011 ; 12( 12): 778-783.[citado 2024 out. 15 ] Available from: https://doi.org/10.1510/icvts.2010.255257Vancouver
Ganem F, Serramo Jr. CV, Blotta MHSL, Souza JA, Nicolau JC, Ramires JAF, Hueb WA. Preoperative B-type natriuretic peptide, and not the inflammation status, predicts an adverse outcome for patients undergoing heart surgery [Internet]. Interactive cardiovascular and thoracic surgery. 2011 ; 12( 12): 778-783.[citado 2024 out. 15 ] Available from: https://doi.org/10.1510/icvts.2010.255257